TP73 and neuroblastoma: We treated two GBM cancer stem cell models, G7 and G26 [48], and a neuroblastoma model, SHY5Y, with TMZ (750 μM for 48 hours), after which we measured the expression of TP73-AS1 using qRT-PCR (Figure 3A).